Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes (GRADE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01794143
Recruitment Status : Completed
First Posted : February 18, 2013
Last Update Posted : June 30, 2021
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Heart, Lung, and Blood Institute (NHLBI)
Becton, Dickinson and Company
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.
Novo Nordisk A/S
Roche Diagnostics
Centers for Disease Control and Prevention
Information provided by (Responsible Party):
GRADE Study Group

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 30, 2021
Study Completion Date : No date given
Publications automatically indexed to this study by Identifier (NCT Number):